Cervical Dystonia Clinical Trial
Official title:
A Trial of Non-invasive Stimulation in Cervical Dystonia
Cervical dystonia (CD) is a common movement disorder. Despite the optimization of botulinum toxin injection (BoNT-A) parameters including muscle selection and dosing, a significant proportion of patients report low levels of satisfaction, and a few of them develop resistance to therapy. The only options for such patients would be invasive therapy such as pallidotomy or pallidal deep brain stimulation. Currently, studies are going on the effectiveness of noninvasive neurostimulation in different neurological disorders. Transcranial Direct Current Stimulation (tDCS) or transcranial pulsed current stimulation (tPCS) are known to be safe non-invasive intervention with almost no side effects that can be used to provide complementary treatment. To detect the dysfunctional regions five min resting state quantitative EEG (qEEG) eyes closed will be recorded and analyzed each time before and after noninvasive stimulation. The investigators will evaluate the efficacy of acute noninvasive stimulation in those CD patients who are already on 3 monthly BoNT-A therapy but the effect of BoNT-A is wearing off in 8 weeks. Kinematics (static and dynamic movements) of neck movements will be recorded using established technology before and after stimulation.
Cervical dystonia (CD) is the most common adult onset dystonia. Abnormal sensorimotor
integration and maladaptive plasticity have been proposed as possible mechanisms. Currently,
there is no definite way to assess and modify this dysfunctional network. Deep brain
stimulation (DBS) is one possible way, but it is invasive and being used in highly selected
patients. Intramuscular injections of botulinum toxin injection (BoNT-A) are successful.
However, 30% patients discontinue due to lack of efficacy, side effects like muscle atrophy
and dysphagia and the effect may wear off by week 8. Importantly, injections don't change the
abnormal networks, as patients need life-long treatment.
Noninvasive brain stimulation (NIBS) is an evolving therapeutic option. Repetitive
transcranial magnetic stimulation (rTMS) has already been used in network modulation in CD.
Although effective, cost, lack of portability and side effects remain issues of rTMS.
Portable, better tolerated and cheaper options using transcranial direct current stimulation
(tDCS) in Parkinson's disease, dystonia, tremor, ataxia and transcranial pulsed current
stimulation (tPCS) in Parkinson's disease are exciting new options. However, with these
methods of NIS, many challenges remain - dysfunctional network localization, selecting
parameters to use, providing adequate stimulation to alter the network consistently, maintain
the therapeutic benefit chronically and have consistent adoption by the patient and clinician
community. These variables make this exciting approach high risk, yet high yield if
successful.
In this study, the investigators will use a new quantitative electroencephalography (qEEG)
technique to first localize global network dysfunction in CD. Kinematic analysis of the
biomechanics of CD will be recorded. The efficacy of acute NIBS will be evaluated in those CD
patients who are already on 3 monthly BoNT-A therapy but the effect of BoNT-A is wearing off
in 8 weeks.The effect will be measured using qEEG and kinematics pre and post stimulation.
Noninvasive stimulation will be delivered through a pair of saline-soaked (0.9% NaCl) surface
sponge electrodes. Stimulation will be given for 20 mins, single session. For the sham
condition, the electrode placement will be same, but the electric current will be ramped down
in 5 seconds after the beginning of the stimulation.
Neurophysiological EEG signals will be recorded, eyes-closed, no-task, using g.Nautilus g.tec
wireless system. The g.tech system uses earclip reference sensors. The subject will be in a
quiet place with less light or electromagnetic perturbations. During the resting state
recordings, patients are seated in a comfortable arm chair and will be instructed to keep
relaxed, with their eyes closed for 5 mins.
A paired t test will be used to compare baseline data and post tPCS data. Descriptive
analysis of the neurological examination findings will be provided.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03617367 -
Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS)
|
Phase 3 | |
Withdrawn |
NCT02180139 -
tDCS in Cervical Dystonia
|
N/A | |
Completed |
NCT00541905 -
Daily Dystonia Practice - A Trial to Investigate NT 201, the Duration of Treatment Effect After One Injection Session and in Long-term Treatment in Cervical Dystonia
|
Phase 4 | |
Unknown status |
NCT00418925 -
Efficacy of Dronabinol for the Treatment of Cervical Dystonia
|
Phase 2 | |
Not yet recruiting |
NCT05715138 -
Comparison of Pallidal With Subthalamic Deep Brain Stimulation for Cervical Dystonia
|
N/A | |
Completed |
NCT02131467 -
Safety and Tolerability of Perampanel in Cervical Dystonia
|
Phase 1/Phase 2 | |
Completed |
NCT02959645 -
Assessment of Brain Activities in Cervical Dystonia
|
||
Completed |
NCT03805152 -
Abobotulinum Toxin and Neubotulinum Toxin Injection in Cerivical Dystonia
|
Phase 3 | |
Completed |
NCT04949594 -
Relief of Pain in Patients With Cervical Dystonia Through the Use of Transcutaneous Electric Nerve Stimulation (TENS)
|
||
Recruiting |
NCT01664013 -
The Impact of Botulinum Toxin Treatment in Quality of Life of Cervical Dystonia Patients
|
Phase 4 | |
Completed |
NCT00447772 -
Study to Assess the Efficacy and Safety of Dysport® in Cervical Dystonia
|
Phase 3 | |
Completed |
NCT00210431 -
Post Marketing Surveillance Study of Dysport
|
||
Completed |
NCT05157100 -
Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia
|
Phase 4 | |
Completed |
NCT00257660 -
Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia
|
Phase 3 | |
Completed |
NCT05103202 -
Efficacy and Safety of 10-Week or Shorter vs 12-Week or Longer Injection Intervals of Botulinum Toxin
|
||
Terminated |
NCT00760318 -
Keppra for Cervical Dystonia
|
Phase 2 | |
Completed |
NCT00323765 -
Plasticity in Cervical Dystonia
|
N/A | |
Completed |
NCT04171258 -
Clinical Trial to Compare the Safety and Efficacy of Botulax® Versus Botox® in Patients With Cervical Dystonia
|
Phase 1 | |
Completed |
NCT04849988 -
A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia
|
Phase 2 | |
Completed |
NCT03471923 -
Non-Motor Features of Cervical Dystonia (CD)
|